Cargando…
Steroid use during COVID-19 infection and hyperglycemia – What a physician should know
BACKGROUND AND AIMS: The COVID-19 pandemic continues to challenge us. Despite several strides in management, steroids remain the mainstay for treating moderate to severe disease and with it arises challenges such as hyperglycemia. The review aims to enhance awareness amongst physicians on steroid us...
Autores principales: | Sosale, Aravind, Sosale, Bhavana, Kesavadev, Jothydev, Chawla, Manoj, Reddy, Sanjay, Saboo, Banshi, Misra, Anoop |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Diabetes India. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189750/ https://www.ncbi.nlm.nih.gov/pubmed/34186344 http://dx.doi.org/10.1016/j.dsx.2021.06.004 |
Ejemplares similares
-
Saroglitazar for the treatment of hypertrig-lyceridemia in patients with type 2 diabetes: current evidence
por: Sosale, Aravind, et al.
Publicado: (2015) -
Blood glucose levels should be considered as a new vital sign indicative of prognosis during hospitalization
por: Kesavadev, Jothydev, et al.
Publicado: (2021) -
Cardiovascular risk factors, micro and macrovascular complications at diagnosis in patients with young onset type 2 diabetes in India: CINDI 2
por: Sosale, Bhavana, et al.
Publicado: (2016) -
Clinical Effectiveness and Impact on Insulin Therapy Cost After Addition of Dapagliflozin to Patients with Uncontrolled Type 2 Diabetes
por: Sosale, Bhavana, et al.
Publicado: (2016) -
Medios– An offline, smartphone-based artificial intelligence algorithm for the diagnosis of diabetic retinopathy
por: Sosale, Bhavana, et al.
Publicado: (2020)